Larimar Therapeutics's total assets for Q2 2025 were $149.99M, a decrease of -11.86% from the previous quarter. LRMR total liabilities were $30.13M for the fiscal quarter, a 16.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.